education
|
points
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Philippines
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Points
Download App
Country
Philippines
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
MIMS home
Drugs
Info
Cinmik
Cinmik
amikacin
Manufacturer:
Karnataka
Distributor:
Phil Pharmawealth
SELECT
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Contraindications
Warnings
Caution For Usage
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Contraindications
Warnings
Caution For Usage
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Contents
Amikacin sulfate
Indications/Uses
Short-term treatment of serious infection. Bacterial septicemia. Resp tract, bone, joint, CNS & skin & soft tissue, intra-abdominal infections, burn, post-op, UTI.
Click to view Cinmik detailed prescribing information
Dosage/Direction for Use
Adult & childn
15 mg/kg daily in equal doses 8-12 hrly IM.
Life-threatening infection
Max: 500 mg 8 hrly.
Uncomplicated UTI
7.5 mg/kg daily in 2 divided doses.
Neonates
Loading dose: 10 mg/kg followed by 15 mg/kg daily in 2 divided doses.
Click to view Cinmik detailed prescribing information
Contraindications
Hypersensitivity to amikacin.
Click to view Cinmik detailed prescribing information
Warnings
For additional cautionary notes to warn of the potential risk of using the medicine...
Click to view Cinmik detailed prescribing information
Special Precautions
Avoid concurrent use w/ other ototoxic or nephrotoxic agents. Kidney function test prior to therapy. Contains Na metabisulfite that may cause anaphylaxis. Pregnancy.
Adverse Reactions
Auditory, vestibular & renal toxicity & neuromuscular blockade. Skin rash, fever, headache, paresthesia, tremor, nausea & vomiting; eosinophilia, arthralgia, anemia & hypotension.
Caution For Usage
For caution against possible variation of physical aspect of medicine...
Click to view Cinmik detailed prescribing information
Storage
View
Cinmik storage
conditions for details to ensure optimal shelf-life.
Description
View
Cinmik description
for details of the chemical structure and excipients (inactive components).
Action
View
Cinmik mechanism of action
for pharmacodynamics and pharmacokinetics details.
MIMS Class
Aminoglycosides
ATC Classification
J01GB06 - amikacin ; Belongs to the class of other aminoglycosides. Used in the systemic treatment of infections.
Regulatory Classification
Rx
Presentation/Packing
Form
Cinmik inj 125 mg/mL
Packing/Price
2 mL x 10 × 1's
Form
Cinmik inj 250 mg/mL
Packing/Price
2 mL x 1's
Form
Cinmik inj 50 mg/mL
Packing/Price
(vial) 2 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in